Searching... Searching...
  • NVP + NA
  • Köp NA
  • Sälj NA
  • Senast NA
  • SEK

  • NEVPF +NA
  • Buy NA
  • Sell NA
  • Latest NA
  • USD

Our board

 

David Laskow-Pooley | Chairman (2017, elected 2016)

Born: 1954

Education: BSc Pharmacy (1st), Pharmaceutical/ Chemical engineering specialty and QP., Sunderland School of Pharmacy.

Other assignments: CEO of Pharmafor Ltd, England, and Director of the Board in Marker Therapeutics Inc. (England) and LREsystem Ltd, (England).

No. of shares in NeuroVive: 30 552

Other: Non-affiliated to the Company, the management and to major owners.

David Bejker

David Bejker | Director (2017)

Born: 1975

Education: M.Sc. (Econ.), Stockholm School of Economics.

Other assignments: CEO of Affibody Medical AB

No. of shares in NeuroVive: 30 552

Other: Non-affiliated to the Company, the management and to major owners.

Anna Malm Bernsten

Jan Törnell | Director (2017)

Born: 1960

Education: MD and PhD in physiology, University of Gothenburg.

Other assignments: CEO and Chairman of Innoext AB, Chairman of LIDDS AB, Chairman of Glactone Pharma AB and Glactone Pharma Development AB, Director of the board of Diaprost AB, Deputy Director of the board of LIDDS Pharma AB and VP and Chief Medical Scientist of Aqilion AB.

No. of shares in NeuroVive: 30 552

Other: Non-affiliated to the Company, the management and to major owners.

Denise Goode | Director (2018)

Born: 1958

Education: Institute of Chartered Accountants in England and Wales Chartered Accountant. B.Sc. Zoology from The University of Manchester (UK)

Other ongoing assignments:  Director of the Board of QED Life Sciences Limited, and VP Business Development in AnaMar AB.

No. of shares in NeuroVive: –

Other: Non-affiliated to the company, the management, and to major owners.

Magnus Persson | Director (2019)

Born: 1960

Education: MD and PhD in physiology, Karolinska Institute, Stockholm.

Other ongoing assignments: Persson is Chairman of the board in Attgeno AB, Cantargia AB,SLS Invest AB, Galecto Biotech AB, Perma Ventures AB, Addi Medical AB, and Addi Optioner AB. Director of the board in Immunicum Aktiebolag, Karolinska Development AB, Själbådan AB, Gyros Protein Technologies Holding AB, Cerecor Inc, and Medical Prognosis Institute A/S.

No. of shares in NeuroVive: –

Other: Non-affiliated to the company, the management, and to major owners.